Adequate 0 8 0 8 O
organ 9 14 9 14 O
function 15 23 15 23 O
as 24 26 24 26 O
defined 27 34 27 34 O
by 35 37 35 37 O
: 37 38 37 38 O
peripheral 39 49 39 49 B-clinical_variable
absolute 50 58 50 58 I-clinical_variable
neutrophil 59 69 59 69 I-clinical_variable
count 70 75 70 75 I-clinical_variable
( 76 77 76 77 I-clinical_variable
ANC 77 80 77 80 I-clinical_variable
) 80 81 80 81 I-clinical_variable
> 82 83 82 83 O
/= 83 85 83 85 O
1,000 86 91 86 91 B-lower_bound
/ 91 92 91 92 I-lower_bound
mm3 92 95 92 95 I-lower_bound
, 95 96 95 96 O
platelet 97 105 97 105 B-clinical_variable
count 106 111 106 111 I-clinical_variable
> 112 113 112 113 O
/= 113 115 113 115 O
100,000 116 123 116 123 B-lower_bound
/ 123 124 123 124 I-lower_bound
mm3 124 127 124 127 I-lower_bound
( 128 129 128 129 O
transfusion 129 140 129 140 O
independent 141 152 141 152 O
defined 153 160 153 160 O
as 161 163 161 163 O
not 164 167 164 167 O
receiving 168 177 168 177 O
platelet 178 186 178 186 O
transfusions 187 199 187 199 O
within 200 206 200 206 O
a 207 208 207 208 O
7 209 210 209 210 B-upper_bound
day 211 214 211 214 I-upper_bound
period 215 221 215 221 I-upper_bound
prior 222 227 222 227 I-upper_bound
to 228 230 228 230 O
enrollment 231 241 231 241 O
) 241 242 241 242 O
, 242 243 242 243 O
hemoglobin 244 254 244 254 B-clinical_variable
> 255 256 255 256 O
/= 256 258 256 258 O
8.0g 259 263 259 263 B-lower_bound
/ 263 264 263 264 I-lower_bound
dl 264 266 264 266 I-lower_bound
( 267 268 267 268 O
may 268 271 268 271 O
receive 272 279 272 279 O
RBC 280 283 280 283 B-treatment
transfusions 284 296 284 296 I-treatment
) 296 297 296 297 O
, 297 298 297 298 O
renal 299 304 299 304 B-clinical_variable
- 304 305 304 305 I-clinical_variable
creatinine 305 315 305 315 I-clinical_variable
< 316 317 316 317 O
/= 317 319 317 319 O
2 320 321 320 321 B-upper_bound
x 322 323 322 323 I-upper_bound
ULN 324 327 324 327 I-upper_bound
; 327 328 327 328 O
hepatic- 329 337 329 337 B-clinical_variable
bilirubin 338 347 338 347 I-clinical_variable
and 348 351 348 351 O
AST 352 355 352 355 B-clinical_variable
< 356 357 356 357 O
/= 357 359 357 359 O
5x 360 362 360 362 B-upper_bound
ULN 363 366 363 366 I-upper_bound
; 366 367 366 367 O
pulmonary 368 377 368 377 O
: 377 378 377 378 O
FVC 379 382 379 382 B-clinical_variable
> 383 384 383 384 O
/=50 384 388 384 388 O
% 388 389 388 389 I-lower_bound
predicted 390 399 390 399 O
, 399 400 399 400 O
Oxyhemoglobin 401 414 401 414 B-clinical_variable
saturation 415 425 415 425 I-clinical_variable
at 426 428 426 428 I-clinical_variable
rest 429 433 429 433 I-clinical_variable
> 434 435 434 435 O
/=95 435 439 435 439 O
% 439 440 439 440 I-lower_bound
( 441 442 441 442 O
off 442 445 442 445 O
supplemental 446 458 446 458 O
oxygen 459 465 459 465 O
) 465 466 465 466 O

Currently 0 9 467 476 O
being 10 15 477 482 O
treated 16 23 483 490 O
with 24 28 491 495 O
bronchodilators 29 44 496 511 B-treatment
or 45 47 512 514 O
corticosteroids 48 63 515 530 B-treatment
or 64 66 531 533 O
known 67 72 534 539 O
to 73 75 540 542 O
have 76 80 543 547 O
active 81 87 548 554 O
asthma 88 94 555 561 B-chronic_disease
. 94 95 561 562 O
This 96 100 563 567 O
will 101 105 568 572 O
not 106 109 573 576 O
include 110 117 577 584 O
patients 118 126 585 593 O
who 127 130 594 597 O
suffered 131 139 598 606 O
from 140 144 607 611 O
asthma 145 151 612 618 O
as 152 154 619 621 O
a 155 156 622 623 O
child 157 162 624 629 O
and 163 166 630 633 O
outgrew 167 174 634 641 O
it 175 177 642 644 O

No 0 2 645 647 O
radiotherapy 3 15 648 660 B-treatment
within 16 22 661 667 O
2 23 24 668 669 B-upper_bound
weeks 25 30 670 675 I-upper_bound

Patient 0 7 676 683 O
age 8 11 684 687 B-age
> 12 13 688 689 O
/= 13 15 689 691 O
12 16 18 692 694 B-lower_bound
years 19 24 695 700 I-lower_bound
and 25 28 701 704 O
< 29 30 705 706 O
/= 30 32 706 708 O
50 33 35 709 711 B-upper_bound
years 36 41 712 717 I-upper_bound

Patients 0 8 718 726 O
receiving 9 18 727 736 O
other 19 24 737 742 O
concurrent 25 35 743 753 O
cancer 36 42 754 760 B-treatment
therapy 43 50 761 768 I-treatment
including 51 60 769 778 O
chemotherapy 61 73 779 791 B-treatment
, 73 74 791 792 O
immunotherapy 75 88 793 806 B-treatment
, 88 89 806 807 O
or 90 92 808 810 O
biologic 93 101 811 819 B-treatment
therapy 102 109 820 827 I-treatment

Performance 0 11 828 839 B-clinical_variable
Status 12 18 840 846 I-clinical_variable
: 18 19 846 847 O
ECOG 20 24 848 852 B-clinical_variable
< 25 26 853 854 O
/= 26 28 854 856 O
2 29 30 857 858 B-lower_bound
for 31 34 859 862 O
patients 35 43 863 871 O
> 44 45 872 873 O
/= 45 47 873 875 O
16 48 50 876 878 B-lower_bound
years 51 56 879 884 I-lower_bound
old 57 60 885 888 O
or 61 63 889 891 O
Lansky 64 70 892 898 B-clinical_variable
play 71 75 899 903 I-clinical_variable
> 76 77 904 905 O
/= 77 79 905 907 O
60 80 82 908 910 B-lower_bound
% 82 83 910 911 I-lower_bound
for 84 87 912 915 O
patients 88 96 916 924 O
< 97 98 925 926 O
/=15 98 102 926 930 O
years 103 108 931 936 I-upper_bound
old 109 112 937 940 O

Pregnant 0 8 941 949 B-pregnancy
or 9 11 950 952 O
breastfeeding 12 25 953 966 O
women 26 31 967 972 B-gender
will 32 36 973 977 O
not 37 40 978 981 O
be 41 43 982 984 O
entered 44 51 985 992 O
into 52 56 993 997 O
this 57 61 998 1002 O
study 62 67 1003 1008 O
due 68 71 1009 1012 O
to 72 74 1013 1015 O
risks 75 80 1016 1021 O
of 81 83 1022 1024 O
fetal 84 89 1025 1030 O
and 90 93 1031 1034 O
teratogenic 94 105 1035 1046 O
adverse 106 113 1047 1054 O
events 114 120 1055 1061 O
as 121 123 1062 1064 O
seen 124 128 1065 1069 O
in 129 131 1070 1072 O
animal 132 138 1073 1079 O
studies 139 146 1080 1087 O
. 146 147 1087 1088 O
Pregnancy 148 157 1089 1098 B-pregnancy
tests 158 163 1099 1104 O
must 164 168 1105 1109 O
be 169 171 1110 1112 O
obtained 172 180 1113 1121 O
in 181 183 1122 1124 O
females 184 191 1125 1132 B-gender
who 192 195 1133 1136 O
are 196 199 1137 1140 O
post 200 204 1141 1145 O
- 204 205 1145 1146 O
menarchal 205 214 1146 1155 O
and 215 218 1156 1159 O
of 219 221 1160 1162 O
child 222 227 1163 1168 O
bearing 228 235 1169 1176 O
potential 236 245 1177 1186 O
( 246 247 1187 1188 O
e.g. 247 251 1188 1192 O
female 252 258 1193 1199 O
that 259 263 1200 1204 O
has 264 267 1205 1208 O
not 268 271 1209 1212 O
been 272 276 1213 1217 O
amenorrheic 277 288 1218 1229 O
for 289 292 1230 1233 O
at 293 295 1234 1236 O
least 296 301 1237 1242 O
12 302 304 1243 1245 B-lower_bound
consecutive 305 316 1246 1257 I-lower_bound
months 317 323 1258 1264 I-lower_bound
or 324 326 1265 1267 O
surgically 327 337 1268 1278 O
sterilized 338 348 1279 1289 O
) 348 349 1289 1290 O

Subjects 0 8 1291 1299 O
who 9 12 1300 1303 O
received 13 21 1304 1312 O
GCB 22 25 1313 1316 B-treatment
systemically 26 38 1317 1329 O
previously 39 49 1330 1340 O
are 50 53 1341 1344 O
eligible 54 62 1345 1353 O
for 63 66 1354 1357 O
participation 67 80 1358 1371 O

Subjects 0 8 1372 1380 O
with 9 13 1381 1385 O
baseline 14 22 1386 1394 O
symptoms 23 31 1395 1403 O
of 32 34 1404 1406 O
fever 35 40 1407 1412 O
and/or 41 47 1413 1419 O
cough 48 53 1420 1425 O
and/or 54 60 1426 1432 O
shortness 61 70 1433 1442 O
of 71 73 1443 1445 O
breath 74 80 1446 1452 O
and/or 81 87 1453 1459 O
wheezing 88 96 1460 1468 O
and/or 97 103 1469 1475 O
fatigue 104 111 1476 1483 B-clinical_variable
grade 112 117 1484 1489 I-clinical_variable
> 118 119 1490 1491 O
/= 119 121 1491 1493 O
2 122 123 1494 1495 B-lower_bound
( 124 125 1496 1497 O
CTCAE 125 130 1497 1502 O
v4.0 131 135 1503 1507 O
) 135 136 1507 1508 O

Uncontrolled 0 12 1509 1521 O
intercurrent 13 25 1522 1534 O
illness 26 33 1535 1542 O
including 34 43 1543 1552 O
, 43 44 1552 1553 O
but 45 48 1554 1557 O
not 49 52 1558 1561 O
limited 53 60 1562 1569 O
to 61 63 1570 1572 O
, 63 64 1572 1573 O
ongoing 65 72 1574 1581 O
or 73 75 1582 1584 O
active 76 82 1585 1591 B-chronic_disease
infection 83 92 1592 1601 I-chronic_disease
, 92 93 1601 1602 O
bradycardia 94 105 1603 1614 B-chronic_disease
, 105 106 1614 1615 O
related 107 114 1616 1623 O
to 115 117 1624 1626 O
cardiac 118 125 1627 1634 B-chronic_disease
disease 126 133 1635 1642 I-chronic_disease
, 133 134 1642 1643 O
bundle 135 141 1644 1650 B-chronic_disease
branch 142 148 1651 1657 I-chronic_disease
block 149 154 1658 1663 I-chronic_disease
, 154 155 1663 1664 O
symptomatic 156 167 1665 1676 B-chronic_disease
congestive 168 178 1677 1687 I-chronic_disease
heart 179 184 1688 1693 I-chronic_disease
failure 185 192 1694 1701 I-chronic_disease
, 192 193 1701 1702 O
unstable 194 202 1703 1711 B-chronic_disease
angina 203 209 1712 1718 I-chronic_disease
pectoris 210 218 1719 1727 I-chronic_disease
, 218 219 1727 1728 O
cardiac 220 227 1729 1736 B-chronic_disease
arrhythmia 228 238 1737 1747 I-chronic_disease
, 238 239 1747 1748 O
or 240 242 1749 1751 O
psychiatric 243 254 1752 1763 B-chronic_disease
illness 255 262 1764 1771 I-chronic_disease
/ 262 263 1771 1772 I-chronic_disease
social 263 269 1772 1778 I-chronic_disease
situations 270 280 1779 1789 I-chronic_disease
that 281 285 1790 1794 O
would 286 291 1795 1800 O
limit 292 297 1801 1806 O
compliance 298 308 1807 1817 O
with 309 313 1818 1822 O
study 314 319 1823 1828 O
requirements 320 332 1829 1841 O

Unresolved 0 10 1842 1852 O
toxicities 11 21 1853 1863 O
from 22 26 1864 1868 O
prior 27 32 1869 1874 O
anticancer 33 43 1875 1885 B-treatment
therapy 44 51 1886 1893 I-treatment
, 51 52 1893 1894 O
defined 53 60 1895 1902 O
as 61 63 1903 1905 O
having 64 70 1906 1912 O
not 71 74 1913 1916 O
resolved 75 83 1917 1925 O
to 84 86 1926 1928 O
NCI 87 90 1929 1932 B-clinical_variable
CTCAE 91 96 1933 1938 I-clinical_variable
Grade 97 102 1939 1944 I-clinical_variable
< 103 104 1945 1946 O
/= 104 106 1946 1948 O
1 107 108 1949 1950 B-upper_bound
with 109 113 1951 1955 O
the 114 117 1956 1959 O
exception 118 127 1960 1969 O
of 128 130 1970 1972 O
alopecia 131 139 1973 1981 B-chronic_disease
and 140 143 1982 1985 O
laboratory 144 154 1986 1996 O
values 155 161 1997 2003 O
listed 162 168 2004 2010 O
per 169 172 2011 2014 O
the 173 176 2015 2018 O
inclusion 177 186 2019 2028 O
criteria 187 195 2029 2037 O
. 195 196 2037 2038 O
Subjects 197 205 2039 2047 O
with 206 210 2048 2052 O
irreversible 211 223 2053 2065 O
toxicity 224 232 2066 2074 O
that 233 237 2075 2079 O
is 238 240 2080 2082 O
not 241 244 2083 2086 O
reasonably 245 255 2087 2097 O
expected 256 264 2098 2106 O
to 265 267 2107 2109 O
be 268 270 2110 2112 O
exacerbated 271 282 2113 2124 O
by 283 285 2125 2127 O
the 286 289 2128 2131 O
investigational 290 305 2132 2147 O
product 306 313 2148 2155 O
may 314 317 2156 2159 O
be 318 320 2160 2162 O
included 321 329 2163 2171 O
( 330 331 2172 2173 O
eg 331 333 2173 2175 O
, 333 334 2175 2176 O
hearing 335 342 2177 2184 O
loss 343 347 2185 2189 O
) 347 348 2189 2190 O

